vs
Pediatrix Medical Group, Inc.（MD）与Ubiquiti Inc.（UI）财务数据对比。点击上方公司名可切换其他公司
Ubiquiti Inc.的季度营收约是Pediatrix Medical Group, Inc.的1.7倍（$814.9M vs $493.8M），Ubiquiti Inc.净利率更高（28.7% vs 6.8%，领先21.8%），Ubiquiti Inc.同比增速更快（35.8% vs -1.7%），过去两年Ubiquiti Inc.的营收复合增速更高（28.6% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Ubiquiti Inc.是一家美国科技企业，2003年于加利福尼亚州圣何塞成立，目前总部位于纽约。公司旗下拥有多个品牌，主营面向企业及家庭用户的有线、无线数据通信产品的研发、生产与销售。
MD vs UI — 直观对比
营收规模更大
UI
是对方的1.7倍
$493.8M
营收增速更快
UI
高出37.5%
-1.7%
净利率更高
UI
高出21.8%
6.8%
两年增速更快
UI
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $814.9M |
| 净利润 | $33.7M | $233.6M |
| 毛利率 | — | 45.9% |
| 营业利润率 | 9.9% | 35.9% |
| 净利率 | 6.8% | 28.7% |
| 营收同比 | -1.7% | 35.8% |
| 净利润同比 | 10.5% | 70.8% |
| 每股收益（稀释后） | $0.40 | $3.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDUI
| Q4 25 | $493.8M | $814.9M | ||
| Q3 25 | $492.9M | $733.8M | ||
| Q2 25 | $468.8M | $759.2M | ||
| Q1 25 | $458.4M | $664.2M | ||
| Q4 24 | $502.4M | $599.9M | ||
| Q3 24 | $511.2M | $550.3M | ||
| Q2 24 | $504.3M | $507.5M | ||
| Q1 24 | $495.1M | $493.0M |
净利润MDUI
| Q4 25 | $33.7M | $233.6M | ||
| Q3 25 | $71.7M | $207.9M | ||
| Q2 25 | $39.3M | $266.7M | ||
| Q1 25 | $20.7M | $180.4M | ||
| Q4 24 | $30.5M | $136.8M | ||
| Q3 24 | $19.4M | $128.0M | ||
| Q2 24 | $-153.0M | $103.8M | ||
| Q1 24 | $4.0M | $76.3M |
毛利率MDUI
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 46.0% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 44.5% | ||
| Q4 24 | — | 41.2% | ||
| Q3 24 | — | 42.1% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 35.3% |
营业利润率MDUI
| Q4 25 | 9.9% | 35.9% | ||
| Q3 25 | 13.8% | 35.7% | ||
| Q2 25 | 12.8% | 34.4% | ||
| Q1 25 | 7.0% | 34.2% | ||
| Q4 24 | 7.8% | 29.8% | ||
| Q3 24 | 6.6% | 30.7% | ||
| Q2 24 | -31.3% | 27.3% | ||
| Q1 24 | 3.2% | 22.6% |
净利率MDUI
| Q4 25 | 6.8% | 28.7% | ||
| Q3 25 | 14.5% | 28.3% | ||
| Q2 25 | 8.4% | 35.1% | ||
| Q1 25 | 4.5% | 27.2% | ||
| Q4 24 | 6.1% | 22.8% | ||
| Q3 24 | 3.8% | 23.3% | ||
| Q2 24 | -30.3% | 20.5% | ||
| Q1 24 | 0.8% | 15.5% |
每股收益（稀释后）MDUI
| Q4 25 | $0.40 | $3.86 | ||
| Q3 25 | $0.84 | $3.43 | ||
| Q2 25 | $0.46 | $4.40 | ||
| Q1 25 | $0.24 | $2.98 | ||
| Q4 24 | $0.37 | $2.26 | ||
| Q3 24 | $0.23 | $2.12 | ||
| Q2 24 | $-1.84 | $1.72 | ||
| Q1 24 | $0.05 | $1.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $302.8M |
| 总债务越低越好 | $570.5M | $47.5M |
| 股东权益账面价值 | $865.9M | $1.0B |
| 总资产 | $2.2B | $1.6B |
| 负债/权益比越低杠杆越低 | 0.66× | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资MDUI
| Q4 25 | $375.2M | $302.8M | ||
| Q3 25 | $340.1M | $177.2M | ||
| Q2 25 | $224.7M | $149.7M | ||
| Q1 25 | $99.0M | $151.0M | ||
| Q4 24 | $229.9M | $133.1M | ||
| Q3 24 | $103.8M | $165.2M | ||
| Q2 24 | $19.4M | $126.3M | ||
| Q1 24 | $8.0M | $102.5M |
总债务MDUI
| Q4 25 | $570.5M | $47.5M | ||
| Q3 25 | $577.2M | $133.8M | ||
| Q2 25 | $583.9M | $250.0M | ||
| Q1 25 | $590.5M | $340.0M | ||
| Q4 24 | $597.1M | $406.3M | ||
| Q3 24 | — | $552.5M | ||
| Q2 24 | — | $708.1M | ||
| Q1 24 | — | $877.5M |
股东权益MDUI
| Q4 25 | $865.9M | $1.0B | ||
| Q3 25 | $890.7M | $828.4M | ||
| Q2 25 | $833.8M | $668.3M | ||
| Q1 25 | $789.2M | $436.1M | ||
| Q4 24 | $764.9M | $290.4M | ||
| Q3 24 | $732.5M | $188.1M | ||
| Q2 24 | $706.5M | $95.1M | ||
| Q1 24 | $856.2M | $25.9M |
总资产MDUI
| Q4 25 | $2.2B | $1.6B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.1B | $1.5B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $2.2B | $1.2B | ||
| Q3 24 | $2.1B | $1.2B | ||
| Q2 24 | $2.0B | $1.2B | ||
| Q1 24 | $2.2B | $1.2B |
负债/权益比MDUI
| Q4 25 | 0.66× | 0.05× | ||
| Q3 25 | 0.65× | 0.16× | ||
| Q2 25 | 0.70× | 0.37× | ||
| Q1 25 | 0.75× | 0.78× | ||
| Q4 24 | 0.78× | 1.40× | ||
| Q3 24 | — | 2.94× | ||
| Q2 24 | — | 7.45× | ||
| Q1 24 | — | 33.92× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $263.9M |
| 自由现金流经营现金流 - 资本支出 | — | $260.3M |
| 自由现金流率自由现金流/营收 | — | 31.9% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | 3.39× | 1.13× |
| 过去12个月自由现金流最近4个季度 | — | $699.5M |
8季度趋势，按日历期对齐
经营现金流MDUI
| Q4 25 | $114.1M | $263.9M | ||
| Q3 25 | $137.3M | $198.5M | ||
| Q2 25 | $137.2M | $130.4M | ||
| Q1 25 | $-117.5M | $123.6M | ||
| Q4 24 | $133.0M | $152.4M | ||
| Q3 24 | $91.8M | $233.7M | ||
| Q2 24 | $107.0M | $231.4M | ||
| Q1 24 | $-125.2M | $163.9M |
自由现金流MDUI
| Q4 25 | — | $260.3M | ||
| Q3 25 | — | $193.3M | ||
| Q2 25 | — | $125.2M | ||
| Q1 25 | — | $120.7M | ||
| Q4 24 | — | $150.4M | ||
| Q3 24 | — | $231.1M | ||
| Q2 24 | — | $229.5M | ||
| Q1 24 | — | $160.6M |
自由现金流率MDUI
| Q4 25 | — | 31.9% | ||
| Q3 25 | — | 26.3% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 18.2% | ||
| Q4 24 | — | 25.1% | ||
| Q3 24 | — | 42.0% | ||
| Q2 24 | — | 45.2% | ||
| Q1 24 | — | 32.6% |
资本支出强度MDUI
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.7% |
现金转化率MDUI
| Q4 25 | 3.39× | 1.13× | ||
| Q3 25 | 1.91× | 0.95× | ||
| Q2 25 | 3.49× | 0.49× | ||
| Q1 25 | -5.66× | 0.68× | ||
| Q4 24 | 4.36× | 1.11× | ||
| Q3 24 | 4.72× | 1.83× | ||
| Q2 24 | — | 2.23× | ||
| Q1 24 | -31.03× | 2.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
UI
| Enterprise Technology | $729.0M | 89% |
| Service Provider Technology | $85.9M | 11% |
